Found: 24
Select item for more details and to access through your institution.
Sodium–glucose co-transporter inhibitors, iron therapy, and checkpoint inhibitors: new clinical and translational pieces of the heart failure puzzle.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4871, doi. 10.1093/eurheartj/ehab857
- By:
- Publication type:
- Article
How an 'accidental doctor' became a renowned cardiologist.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4876, doi. 10.1093/eurheartj/ehab305
- By:
- Publication type:
- Article
Making connections to overcome arrhythmias.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4878, doi. 10.1093/eurheartj/ehab311
- By:
- Publication type:
- Article
Leveraging non-coding RNAs to fight cardiovascular disease: the EU-CardioRNA network.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4881, doi. 10.1093/eurheartj/ehab326
- By:
- Publication type:
- Article
Appointment as Board Reviewer: Ik-Kyung Jang, MD, PhD.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4884, doi. 10.1093/eurheartj/ehab322
- By:
- Publication type:
- Article
Quadruple combination of quarter doses of blood pressure-lowering agents: a string QUARTET in the symphony of hypertension management?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4885, doi. 10.1093/eurheartj/ehab733
- By:
- Publication type:
- Article
Sodium glucose co-transporter inhibitors and heart failure outcomes across different patient populations.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4887, doi. 10.1093/eurheartj/ehab704
- By:
- Publication type:
- Article
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4891, doi. 10.1093/eurheartj/ehab497
- By:
- Publication type:
- Article
Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
SGLT2 inhibitors: the story continues to unfold.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4902, doi. 10.1093/eurheartj/ehab561
- By:
- Publication type:
- Article
Para-aortic channel in congenital heart disease: computed tomography and transoesophageal echography depiction of an undescribed type of interatrial communication.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4905, doi. 10.1093/eurheartj/ehab411
- By:
- Publication type:
- Article
Intravenous iron supplementation: novel anti-remodelling therapy for patients with heart failure?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4915, doi. 10.1093/eurheartj/ehab624
- By:
- Publication type:
- Article
Prognostic value of comprehensive intracoronary physiology assessment early after heart transplantation.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4918, doi. 10.1093/eurheartj/ehab568
- By:
- Publication type:
- Article
Spontaneous intramyocardial haemorrhage in a patient with wild-type transthyretin cardiac amyloidosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Early diagnosis of cardiac allograft vasculopathy: biopsy, liquid biopsy, non-invasive imaging, coronary imaging, or coronary physiology?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4930, doi. 10.1093/eurheartj/ehab722
- By:
- Publication type:
- Article
Stanford experience of heart transplantation over five decades.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4934, doi. 10.1093/eurheartj/ehab416
- By:
- Publication type:
- Article
Improving survival after heart transplantation despite increasing complexity.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4944, doi. 10.1093/eurheartj/ehab517
- By:
- Publication type:
- Article
Effects of canagliflozin on human myocardial redox signalling: clinical implications.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4947, doi. 10.1093/eurheartj/ehab420
- By:
- Publication type:
- Article
Canagliflozin and myocardial oxidative stress: SGLT1 inhibition takes centre stage.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4961, doi. 10.1093/eurheartj/ehab519
- By:
- Publication type:
- Article
Cardiovascular immunotoxicities associated with immune checkpoint inhibitors: a safety meta-analysis.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4964, doi. 10.1093/eurheartj/ehab618
- By:
- Publication type:
- Article
Immune checkpoint inhibitors and cardiovascular events among patients with cancer: a window into the critical role of the immune system in cardiovascular biology.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4978, doi. 10.1093/eurheartj/ehab708
- By:
- Publication type:
- Article
Percutaneous intervention in patients with cancer: can we offer an improvement in safety?
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4981, doi. 10.1093/eurheartj/ehab401
- By:
- Publication type:
- Article
Decision making in percutaneous coronary intervention in patients with cancer: balancing ischaemic and bleeding risk.
- Published in:
- European Heart Journal, 2021, v. 42, n. 48, p. 4982, doi. 10.1093/eurheartj/ehab403
- By:
- Publication type:
- Article